Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04612738 · ClinicalTrials.gov registry record · NA

Project Talk Trial: Engaging Underserved Communities in End-of-life Conversations

A NA study of Communication and Advance Care Planning, sponsored by Milton S. Hershey Medical Center.

Recruiting
Registry status
NA
Development phase
1,500
Enrollment target
20
Study locations

NCT04612738 is a NA study of Communication and Advance Care Planning that is actively recruiting participants, run by Milton S. Hershey Medical Center. The registered enrollment target is 1,500 participants, roughly in line with the 1,377-participant average among 34 other Communication trials with a reported enrollment target. The trial reports 20 study locations across 8 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04612738, a NA study of Communication and Advance Care Planning, is actively recruiting participants, sponsored by Milton S. Hershey Medical Center.

RECRUITING
Registry status
NA
Development phase
1,500 participants
Enrollment target
20
Study locations

Study Summary

Compared to the general population, individuals from underserved communities are more likely to receive low quality end-of-life care and unwanted, costly and burdensome treatments due in part to a lack of advance care planning (ACP; the process of discussing wishes for end-of-life care with loved ones/clinicians and documenting them in advance directives). This study will use existing, trusted, and respected social networks to evaluate two conversation-based tools intended to engage underserved individuals in discussions about end-of-life issue and motivate them to carry out ACP behaviors. Through this study, investigators will learn how best to engage underserved populations in ACP so as to: 1) increase the likelihood that patients from underserved communities will receive high-quality end-of-life care; 2) address health disparities related to end-of-life treatments; and 3) reduce unnecessary suffering for patients and their families.

Interventions

  • BEHAVIORAL Hello (serious game)
  • BEHAVIORAL The Conversation Project (CP) Starter Kit
  • OTHER Table Topics (general conversation game)

Study Locations (20)

Florida

  • DeSoto Memorial Hospital - Arcadia
  • High Point Neighborhood Family Center - Clearwater
  • St. Phillip AME Church - Tallahassee
  • City of Temple Terrace, Omar K. Lightfoot Center - Temple Terrace
  • 47Million Reasons Healthcare Movement - West Palm Beach

Georgia

  • Phoebe Putney Memorial Hospital - Albany
  • Helene S. Mills - Atlanta
  • Seniors First of GA - Atlanta
  • Gilmer County Senior Center - Ellijay

Arizona

  • Kingman Regional Medical Center - Kingman
  • Accord Health Group - Show Low
  • El Rio Neighborhood Center - Tucson

California

  • Promotores y Promotoras - Santa Paula
  • Our Lady of Solitude - Soledad
  • Vitas - Walnut Creek

Colorado

  • University of Colorado Hospital - Aurora
  • HopeWest Montrose - Montrose

Alabama

  • Pincham-Lincoln Community Center - Athens

Connecticut

  • Stamford Senior Center - Stamford

District of Columbia

  • MedStar Washington Hospital Center - Washington D.C.

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2022-03-19
Est. Completion 2026-01-31
Phase NA

Sponsor

Milton S. Hershey Medical Center

396 total trials

What the Registry Record Tells You About NCT04612738

The ClinicalTrials.gov registry entry for NCT04612738 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 1,377-participant average among 34 other Communication trials with a reported enrollment target. The listed sponsor is Milton S. Hershey Medical Center, which has 396 total studies on file at ClinicalTrials.gov.

The record links to 5 conditions, with Communication appearing as the primary indexed condition, and to 3 interventions - of which Hello (serious game) is the first listed.

NCT04612738 reports 20 study locations spanning 8 distinct geographic areas - top geographies include Florida, Georgia, Arizona.

Frequently Asked Questions

What is clinical trial NCT04612738 about?

NCT04612738 is a clinical study titled "Project Talk Trial: Engaging Underserved Communities in End-of-life Conversations". Compared to the general population, individuals from underserved communities are more likely to receive low quality end-of-life care and unwanted, costly and burdensome treatments due in part to a lack of advance care planning (ACP; the process of discussing wishes for end-of-life care with loved on...

What is the current status of trial NCT04612738?

This trial is currently recruiting. It is a NA study. The enrollment target is 1,500 participants. The study started on 2022-03-19. Estimated completion is 2026-01-31.

What conditions does trial NCT04612738 study?

This clinical trial studies the following conditions: Communication, Advance Care Planning, Chronic Illness, Terminal Illness, Advance Directives.

What interventions are being tested in trial NCT04612738?

The interventions under investigation include: Hello (serious game) (BEHAVIORAL), The Conversation Project (CP) Starter Kit (BEHAVIORAL), Table Topics (general conversation game) (OTHER).

Who is sponsoring clinical trial NCT04612738?

This trial is sponsored by Milton S. Hershey Medical Center, which has 396 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04612738 being conducted?

This trial has 20 study locations across Alabama, Arizona, California, Colorado, Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Communication

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.